These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8684234)
21. [Tacrine in the treatment of Alzheimer's disease]. Weinstein HC; Teunisse S; van Gool WA; van Crevel H Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1575-7. PubMed ID: 1922487 [No Abstract] [Full Text] [Related]
23. Tacrine and lecithin in Alzheimer's disease. BMJ; 1990 Apr; 300(6729):939-40. PubMed ID: 2337722 [No Abstract] [Full Text] [Related]
24. Effect of tacrine in Alzheimer's disease: or non-effect? Broe GA; Creasey H Med J Aust; 1994 Sep; 161(6):348-9. PubMed ID: 8090107 [No Abstract] [Full Text] [Related]
25. Tacrine and lecithin in Alzheimer's disease. Patient heterogeneity explains varied response. Levy R BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019288 [No Abstract] [Full Text] [Related]
26. Lewy bodies and response to tacrine in Alzheimer's disease. Levy R; Eagger S; Griffiths M; Perry E; Honavar M; Dean A; Lantos P Lancet; 1994 Jan; 343(8890):176. PubMed ID: 7904023 [No Abstract] [Full Text] [Related]
27. Pharmacoepidemiology of tacrine in Alzheimer's disease. Begaud B; Haramburu F; Miremont G Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701 [No Abstract] [Full Text] [Related]
28. Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified. Wilcock GK BMJ; 1994 Jun; 308(6942):1507. PubMed ID: 8019291 [No Abstract] [Full Text] [Related]
35. Measurement of cholinergic drug effects on memory in Alzheimer's disease. Brinkman SD; Gershon S Neurobiol Aging; 1983; 4(2):139-45. PubMed ID: 6355883 [TBL] [Abstract][Full Text] [Related]
36. [New studies on Alzheimer's disease. Promising therapeutic results with tacrine]. Nordberg A; Viitanen M; Winblad B Lakartidningen; 1993 Apr; 90(16):1561-3. PubMed ID: 8483354 [No Abstract] [Full Text] [Related]
37. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817 [TBL] [Abstract][Full Text] [Related]
38. [The cholinergic perspectives in the treatment of Alzheimer's disease: tacrine]. Royuela Rico A; Macías Fernández JA Rev Clin Esp; 1995 Jul; 195(7):473-8. PubMed ID: 7667523 [No Abstract] [Full Text] [Related]
39. Tacrine for Alzheimer's disease. Costs and benefits. Knopman D Pharmacoeconomics; 1995 Apr; 7(4):275-9. PubMed ID: 10172459 [No Abstract] [Full Text] [Related]
40. Tacrine for Alzheimer's disease. Med Lett Drugs Ther; 1993 Sep; 35(905):87-8. PubMed ID: 8361451 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]